These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2289582)

  • 1. [Primary study of iontophoresis of zinc ion in treatment of retinitis pigmentosa].
    Mao W; Zeng L; Ma Q; Chen Y; Dai Z; Tang P; Guo X; Li D; Su W
    Yan Ke Xue Bao; 1990 Dec; 6(3-4):88-90. PubMed ID: 2289582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of acetazolamide on visual function in retinitis pigmentosa.
    Greenstein VC; Holopigian K; Siderides E; Seiple W; Carr RE
    Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):269-73. PubMed ID: 8425835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum zinc levels in retinitis pigmentosa.
    Karcioglu ZA; Stout R; Hahn HJ
    Curr Eye Res; 1984 Aug; 3(8):1043-8. PubMed ID: 6333320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of complex treatment of retinitis pigmentosa on the results of pupillography].
    Kecik D; Lewandowski P; Zajkowska G; Paszkiewicz M; Kasprzak J
    Klin Oczna; 1992; 94(2-3):62-3. PubMed ID: 1640684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
    Birch DG; Anderson JL; Fish GE
    Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial.
    Rotenstreich Y; Belkin M; Sadetzki S; Chetrit A; Ferman-Attar G; Sher I; Harari A; Shaish A; Harats D
    JAMA Ophthalmol; 2013 Aug; 131(8):985-92. PubMed ID: 23700011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of retinitis pigmentosa. 8 patients treated for retinitis pigmentosa/Usher syndrome in Cuba].
    Hetland JG
    Tidsskr Nor Laegeforen; 1994 May; 114(13):1515-6. PubMed ID: 8079244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual Function in Carriers of X-Linked Retinitis Pigmentosa.
    Comander J; Weigel-DiFranco C; Sandberg MA; Berson EL
    Ophthalmology; 2015 Sep; 122(9):1899-906. PubMed ID: 26143542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Variability of visual acuity, dark adaptation and electroretinogram in retinitis pigmentosa].
    Niemeyer G; Gurewitsch K
    Klin Monbl Augenheilkd; 1982 May; 180(5):401-4. PubMed ID: 7109486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiological study on the retinitis pigmentosa].
    Imaizumi K
    Nippon Ganka Gakkai Zasshi; 1969 Nov; 73(11):2347-496. PubMed ID: 5391946
    [No Abstract]   [Full Text] [Related]  

  • 11. Levels of zinc in plasma, erythrocytes, and hair, and levels of serum copper in patients with retinitis pigmentosa in Turkey.
    Atmaca LS; Arcasoy A; Cavdar AO; Ozmert E
    Br J Ophthalmol; 1989 Jan; 73(1):29-31. PubMed ID: 2920151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
    Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
    Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photopic electroretinogram implicit time in retinitis pigmentosa.
    Iijima H; Yamaguchi S; Hosaka O
    Jpn J Ophthalmol; 1993; 37(2):130-5. PubMed ID: 8230836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperosmolarity response of ocular standing potential as a clinical test for retinal pigment epithelium activity. Chorioretinal dystrophies.
    Yonemura D; Kawasaki K; Madachi-Yamamoto S
    Doc Ophthalmol; 1984 May; 57(3):163-73. PubMed ID: 6432505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoaversion in retinitis pigmentosa.
    Gawande AA; Donovan WJ; Ginsburg AP; Marmor MF
    Br J Ophthalmol; 1989 Feb; 73(2):115-20. PubMed ID: 2930757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
    Berson EL; Grimsby JL; Adams SM; McGee TL; Sweklo E; Pierce EA; Sandberg MA; Dryja TP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2217-24. PubMed ID: 11527933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screen of the IMPDH1 gene among patients with dominant retinitis pigmentosa and clinical features associated with the most common mutation, Asp226Asn.
    Wada Y; Sandberg MA; McGee TL; Stillberger MA; Berson EL; Dryja TP
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1735-41. PubMed ID: 15851576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
    Nagy D; Schönfisch B; Zrenner E; Jägle H
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient pupillary light reflex in relation to fundus autofluorescence and dark-adapted perimetry in typical retinitis pigmentosa.
    Liu Y; Liu DN; Meng XH; Yin ZQ
    Ophthalmic Res; 2012; 47(3):113-21. PubMed ID: 21997281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on treatment of retinitis pigmentosa with traditional Chinese medicine by Flicker electroretinogram].
    Wu XW; Tang YZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Jun; 16(6):336-9. PubMed ID: 9387760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.